Pharmacokinetics Distribution of Raltegravir by PET/MR
Last updated on July 2021Recruitment
- Recruitment Status
- Recruiting
- Estimated Enrollment
- Same as current
Summary
- Conditions
- HIV -1 Infection
- Type
- Interventional
- Phase
- Early Phase 1
- Design
- Allocation: N/AIntervention Model: Single Group AssignmentMasking: None (Open Label)Primary Purpose: Other
Participation Requirements
- Age
- Between 18 years and 125 years
- Gender
- Both males and females
Description
Not Provided
Not Provided
Tracking Information
- NCT #
- NCT03174977
- Collaborators
- Merck Sharp & Dohme Corp.
- Investigators
- Principal Investigator: Timothy J Henrich, MD University of California, San Francisco
Get Well Soon